Raul Santos Gave 2 Talks at SAC 2025: On The Role of LDL-C and Future of Lipid-lowering Therapies
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn:
”I had the privilege of giving two talks at the Argentinian Society of Cardiology (SAC) congress in Buenos Aires.
The first talk focused on the role of LDL-C in atherosclerosis, presenting overwhelming data and evidence to support this understanding.
It was great to work with Drs. Melina Huerin and Walter Masson on this.
The second talk explored the future of lipid-lowering therapies, highlighting the role of genetics in paving the way for newer therapies targeting LDL, triglycerides, and Lp(a).
Additionally, I had the opportunity to collaborate with Pablo Corral on a meeting with colleagues from the Argentinian Lipid Society (SAL).
During this meeting, we discussed the current challenges in reducing the burden of ASCVD and explored potential actions to address the residual risk associated with various factors, including LDL-C, Lp(a), triglycerides, inflammation, obesity, and thrombosis.
Many good things will come in the near future.
I’d like to thank SAC and Novartis Argentina for the opportunity.”
Stay updated with Hemostasis Today.
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
-
Jan 29, 2026, 05:09Edina Cenko on Expanding Cardiovascular Risk: From Ischaemia to Emerging Frontiers
-
Jan 29, 2026, 04:58Anna Randi Shares the Latest Episode of The VWF and Angiogenesis Story from Her Lab
-
Jan 29, 2026, 04:49Ruah Alyamany on Her Contribution to Establishing The Role of IgM in APS